nVerses Capital’s Veracyte VCYT Stock Holding History

nVerses Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,500	Closed	-$221K	–	862
2024 Q3	$221K	Buy	6,500 +2,600	+67%	+$73.1K	0.1%	302
2024 Q2	$84.5K	Buy	+3,900	New	+$82K	0.05%	477

Other funds holding VCYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

nVerses Capital's VCYT Position: Q4 2024 in Review

nVerses Capital sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 6,500 shares — an estimated $221K sold.

nVerses Capital first reported a position in VCYT in Q2 2024 and held it in 2 quarters. The position peaked at $221K in Q3 2024. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.

nVerses Capital reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 6,500 Veracyte shares in Q4 2024, an estimated $221K.
nVerses Capital first reported a position in Veracyte in Q2 2024 and held it in 2 quarters.
nVerses Capital's Veracyte position peaked at $221K in Q3 2024.
318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.